Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | NPY4R | P50391 | 9/20 | 0.41 |
| ▸ | NPY1R | P25929 | 5/20 | 0.41 |
| ▸ | NPY2R | P49146 | 4/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.41 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
| ▸ | OTC | P00480 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28608119 | 1.00 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL23610947 | 0.87 | DPP7 (0.61) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL23626315 | 0.87 | DPP7 (0.61) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL4104140 | 0.86 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL197663 | 0.86 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6868746 | 0.86 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL7326934 | 0.84 | DPP7 (0.49) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| Hydrochloric Acid SCHEMBL2132822 | 0.84 | DPP7 (0.45) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL1388277 | 0.84 | DPP7 (0.49) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL15165702 | 0.84 | DPP7 (0.49) | DPP7NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958325-B2 | Cationic polysaccharide compositions | EFRAT BIOPOLYMERS LIMITED (IL) | 2005-10-25 | — | — | US | disclosed |
| US-20020146826-A1 | Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics | POLYGENE LTD. | 2002-10-10 | — | — | US | disclosed |
| EP-1222926-A1 | Cationic polysaccharide compositions | Polygene Ltd. (IL) | 2002-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020146826-A1 | Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics | ALG1, CD44, CHIT1 | DPP7 708/4885NPY4R 2602/4885NPY1R 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.